Tere hommikut,<br /><br />Täna on kolm head uudist:<br /><br />Oracle sai pos. kommentaare Wells Fargo analüütikutelt<br />Nokia hinnasihti tõsteti BofA poolt<br />HPQ tulemused ei olnud pommiks.<br /><br />Neg. poole pealt on meil:<br /><br />Novelluse mid.q. update, mille kohta arvatakse nii:<br /><br /><b>NVLS Novellus expected to cut Sept outlook to down 30%</b> - Piper Jaffray (25.14) <br /><br />USB Piper Jaffray expects NVLS during their Aug 29 mid-qtr update to revise its order guidance outlook downward for the Sept qtr from -10% sequentially to down as much as 30%; in addition, firm also believes that the front-end semi equipment co's as a group will experience sequential order declines of 25%-30% in Q3 vs previous est of -20%; KLAC should fare better than the group avg, or possibly down 10%-15% sequentially, while LRCX and NVLS will likely perform at the low end of the range, or -30%. Believes that Q4 orders could be down sequentially from Sept and that the next uptick in orders could occur during 1H03 <br /><br />Tehniline pilt on pigem neg:<br /><br /><br /> <img src="/images/files/ACF8500.gif"><br /><br />Arko Kadajane tegi hea graafiku ja biotechide kohta. Pidu hakkab lõpule jõudma just nii nagu varem juba sai ennustatud:<br /><br /> <img src="/images/files/ACF7224.png"><br /><br /><br />Üheks heaks näiteks selle kohta on ka <b>Celegne (CELG)</b>, millest Arko kirjutas eile ka terve loo:<br /><br /> <img src="/images/files/ACF7219.png"><br /><br /><b>ETrade (ET)</B> ning tema konkurent <b>Schwab (SCH)</b> näitavad sarnaselt kogu turuga nõrkuse märke. Siiski peaksid ostjad olema vähemalt ET puhul tasemetel 4.25-4.50 juba ees ootamas. <br /><br /> <img src="/images/files/ACF7215.png"> <br /><img src="/images/files/ACF7217.png"><br /><br />sB<br />